Patent · US Expired

[2-(1H-indol-1-yl)ethyl]-2-piperazine and pyrido[1,2-a]indol-9-one as intermediates for pyrazino(2,3-3,4)pyrido(1,2-a) indoles which are useful for treating hypertension in mammals

US4515949A · kind A · utility

2Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 27, 1984
Grant dateMay 7, 1985
Priority date
Expiry dateFeb 27, 2004

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound of the formula ##STR1## in which R.sup.1 is hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl; PA1 R.sup.2 is hydrogen or lower alkyl having one to three carbon atoms; and PA1 R.sup.5 is benzyl or lower alkyl; and a compound of the formula ##STR2## in which R.sup.1 is hydrogen, halogen, lower alkyl, lower alkoxy or trifluoromethyl; PA1 R.sup.2 is hydrogen or lower alkyl having one to three carbon atoms; and PA1 X is bromo or chloro, or hydrogen; as intermediates for pyrazino(2,3-3,4) pyrido (1,2-a) indoles which are useful for treating hypertension in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.